Toray Q1 Core Operating Income Jumps 67% to ¥48.4 Billion as Carbon Fiber Revenue Surges 34%

Toray Industries, Inc. (TSE: 3402) reported consolidated first-quarter results under IFRS on August 6. The figures cover the three months from April 1 to June 30, 2026 — the opening quarter of the year ending March 2027. Revenue rose 14.0% to ¥678,967 million, core operating income — the company's headline profit measure, defined as operating income excluding non-recurring gains and losses — climbed 66.6% to ¥48,432 million, and operating income rose 72.1% to ¥47,330 million. Profit before tax was ¥49,069 million, up 73.8%, and profit attributable to owners of the parent reached ¥31,262 million, up 82.3%. Basic earnings per share almost doubled, to ¥21.47 from ¥11.16.

The comparison base flatters those percentages and should be stated plainly: in the same quarter a year earlier Toray's core operating income had fallen 20.9% and parent profit had dropped 36.1%. This quarter is a recovery from a weak period, not a step onto new ground. Even so, the absolute numbers are the group's strongest opening quarter in years, and the improvement is unusually broad — all four reportable segments and the "Other" grouping raised revenue and profit simultaneously, which is not something Toray has managed often across a portfolio spanning apparel fibres, engineering plastics, optical and capacitor films, carbon fiber and reverse-osmosis membranes.

Profit grew nearly five times faster than revenue

The operating leverage is visible line by line. Gross profit rose 21.9% to ¥147,252 million on cost of sales of ¥531,715 million, lifting the gross margin to 21.7% from 20.3%. Selling, general and administrative expenses grew only 9.6% to ¥100,658 million — well below the 14.0% revenue increase — and other income more than tripled to ¥3,705 million against other expenses of ¥2,969 million. The core operating margin widened to 7.1% from 4.9%. Bridging core operating income to reported operating income, Toray added a ¥1,035 million gain on the sale of fixed assets and deducted a ¥1,828 million loss on disposal and a ¥309 million impairment charge, arriving at ¥47,330 million. Below that line, finance income of ¥2,748 million and finance costs of ¥5,116 million were roughly offset, while equity-method income rose to ¥4,107 million from ¥3,059 million, carrying profit before tax to ¥49,069 million. Income tax expense of ¥15,088 million implies an effective rate of 30.7%, down from 34.1%. Total comprehensive income reached ¥35,792 million, up 149.9%, helped by a ¥19,720 million foreign-currency translation gain. One further mechanical point matters: earnings per share rose 92.4% against an 82.3% rise in parent profit, because the weighted average share count fell 5.3% to 1,456,336,917 from 1,537,324,791 after the ¥33,435 million buyback Toray executed in the equivalent quarter a year ago.

Four segments instead of five, effective this quarter

Toray changed its reporting structure with this filing. Under "IGNITION 2028", the medium-term management programme launched in fiscal 2026 and built around return on invested capital as its governing metric, the group repositioned its water-treatment and its pharmaceutical and medical devices businesses as activities sharing a single value axis — human health and quality of life — and merged them into a new Water Treatment & Healthcare segment. Reportable segments therefore fall from five (Fibers & Textiles, Performance Chemicals, Carbon Fiber Composite Materials, Environment & Engineering, and Life Science) to four, with the residual engineering, industrial machinery, housing and construction materials and analysis-services activities now sitting inside "Other". Prior-year segment figures have been restated on the new basis, so the comparisons below are like-for-like.

Fibers & Textiles: price pass-through against a raw-material shock

The group's largest business by revenue posted external sales of ¥259,898 million, up 8.3%, and core operating income of ¥17,972 million, up 18.3%, for a margin of 6.9% against 6.3%. Apparel applications ran into intensified competition from overseas products, and Toray said it concentrated on capturing what demand there was. Industrial applications, led by automotive, returned to a moderate recovery. Both were hit by the surge in raw-material prices flowing from the deterioration of the Middle East situation, and the company's response was explicit: emergency price pass-through combined with cost improvement. That this segment still expanded its margin while absorbing a feedstock shock is the clearest evidence in the filing that Toray's pricing discipline is holding.

Performance Chemicals: films for capacitors and optics drive a 69% profit jump

Performance Chemicals was the quarter's single biggest profit contributor. External revenue rose 14.1% to ¥251,092 million and core operating income jumped 69.4% to ¥23,054 million, widening the margin to 9.0% from 6.1%. Resins and chemicals faced the same Middle East-driven feedstock inflation but pushed price increases through while volumes held solid. Films were the standout: sales into multilayer ceramic capacitors and other electronic-component uses, and into optical applications, both ran strongly — a direct read-through from the AI and semiconductor investment cycle that the company cited as the main support for an otherwise uncertain global economy. Electronic and information materials were mixed: OLED-related and circuit materials suffered from weak Chinese panel demand and intensified competition, while power-inductor applications grew.

Carbon Fiber Composite Materials: aerospace lifts revenue 34%

The fastest-growing part of the group, and the one that most defines Toray's global position as the world's largest carbon fiber producer, delivered external revenue of ¥89,663 million, up 34.1%, and core operating income of ¥7,927 million, up 71.3% — a margin of 8.8% against 6.9%. Toray attributed the advance to steady expansion in aerospace and in space and defence applications, with sports and general industrial uses also on a recovering trend. The filing does not break out volume against price, nor does it quantify individual end-markets, so the aerospace attribution should be read as management's qualitative characterisation rather than a disclosed split. On external revenue the segment is still only 13% of the group; on incremental profit it contributed ¥3,300 million of the ¥18,954 million rise in aggregate segment profit.

Water Treatment & Healthcare and Other

The newly constituted Water Treatment & Healthcare segment more than doubled its profit, with external revenue up 13.8% to ¥40,740 million and core operating income up 126.6% to ¥3,136 million, taking the margin to 7.7% from 3.9%. In water treatment, weak Chinese market conditions persisted, but reverse-osmosis membrane shipments for a large Middle East project and solid sales in the Americas — the business's principal market — carried the result. In pharmaceuticals and medical devices, drug sales were sluggish; the improvement came from shifting the blood-dialyser line-up towards higher value-added products and from cost reduction. The "Other" grouping — comprehensive engineering, industrial machinery, housing, building and civil engineering materials, and analysis and testing services — lifted external revenue 13.2% to ¥37,574 million and more than tripled core operating income to ¥2,439 million from ¥763 million. Corporate items subtracted ¥6,096 million against ¥6,501 million a year earlier, of which unallocated headquarters research expense was ¥5,981 million.

A ¥3.49 trillion balance sheet inflated by the weaker yen

Total assets stood at ¥3,492,091 million at June 30, only ¥15,115 million above the March year-end, with both sides of the balance sheet lifted by the yen translation of overseas subsidiaries. Inventories built up to ¥576,065 million from ¥538,586 million, and assets held for sale jumped to ¥36,597 million from ¥453 million, offsetting declines in trade and other receivables (to ¥620,771 million from ¥642,708 million) and in retirement benefit assets (to ¥90,098 million from ¥114,474 million, after a ¥15,346 million remeasurement loss). Liabilities fell ¥4,986 million to ¥1,544,154 million, driven by current bonds and borrowings dropping to ¥366,627 million from ¥380,968 million and deferred tax liabilities to ¥50,501 million from ¥56,534 million, partly offset by non-current bonds and borrowings rising to ¥494,947 million. Equity rose ¥20,101 million to ¥1,947,937 million, mainly through other components of equity; equity attributable to owners of the parent reached ¥1,817,139 million and the ratio of equity attributable to owners of the parent improved to 52.0% from 51.8%. Shares issued were unchanged at 1,504,481,403, with treasury shares easing to 47,819,230 from 48,344,096.

Cash flow: inventories absorbed most of the earnings gain

This is the quarter's principal caveat. Operating cash flow rose only 8.6% to ¥54,131 million against an 82.6% rise in profit, because working capital consumed the difference: inventories drew ¥37,913 million of cash against ¥16,356 million a year earlier, and the release from receivables shrank to ¥21,502 million from ¥33,011 million, only partly offset by trade payables contributing ¥12,080 million against a ¥7,563 million outflow. Depreciation and amortisation was ¥34,069 million. A far lighter tax bill helped — income taxes paid fell to ¥16,692 million from ¥38,790 million — but the operating subtotal before interest and tax actually fell, to ¥71,802 million from ¥87,923 million. Investing outflows narrowed to ¥33,186 million from ¥50,607 million as purchases of property, plant, equipment and intangibles were cut 34.8% to ¥32,746 million, so free cash flow swung to a positive ¥20,945 million from a negative ¥751 million. Financing was an outflow of ¥25,005 million against ¥4,953 million, the difference being last year's ¥53,931 million net short-term borrowing raised alongside the buyback; this year net short-term borrowings barely moved at ¥589 million, long-term proceeds of ¥18,539 million ran below ¥25,762 million of repayments, dividends took ¥14,145 million from parent shareholders and ¥2,098 million from non-controlling interests, and there were no treasury share purchases. Cash and equivalents closed at ¥263,929 million, against ¥228,608 million a year earlier.

Interim guidance raised, full year untouched, dividend up 30%

Toray revised its first-half forecast upward. Cumulative six-month revenue is now guided to ¥1,390.0 billion from ¥1,370.0 billion, core operating income to ¥87.0 billion from ¥73.0 billion — a 19.2% increase to the target — and interim profit attributable to owners of the parent to ¥45.0 billion from ¥40.0 billion, with interim EPS of ¥30.90 against ¥27.48. Measured against the prior-year interim actuals of ¥1,234.3 billion, ¥67.9 billion and ¥36.9 billion, that is growth of 12.6%, 28.2% and 21.8%. The implied second quarter is notably more cautious than the first: ¥38.6 billion of core operating income against the ¥48.4 billion just delivered. Management is assuming ¥155 to the dollar for July to September, and flags Middle East-driven fuel and raw-material price spikes and supply constraints, US trade and foreign policy, the trajectory of AI-related demand and continued Chinese weakness as the swing factors. Full-year guidance was left unchanged at revenue of ¥2,830.0 billion (+9.5%), core operating income of ¥160.0 billion (+12.7%), parent profit of ¥90.0 billion (+13.2%) and EPS of ¥61.80 — figures the company says it will revisit at the second-quarter announcement. The first quarter alone has already delivered 30.3% of the full-year core operating income target and 34.7% of the profit target. The dividend forecast is unrevised and generous: an annual ¥26.00 per share against ¥20.00 last year, a 30% increase, split into an interim ¥13.00 — comprising a ¥10.00 ordinary dividend plus a ¥3.00 commemorative dividend — and a year-end ¥13.00.

Soda Aromatic sold to Samyang, ¥8 billion gain due in the second quarter

One transaction sits between the balance sheet and the guidance. On May 29, 2026, Toray signed a share transfer agreement to sell its entire 66% holding in Soda Aromatic Co., Ltd., a Performance Chemicals subsidiary, jointly with Mitsui & Co., which held the remaining 34%, to Samyang Japan Co., Ltd., a subsidiary established by South Korea's Samyang Corporation. At June 30 the company had classified ¥27,303 million of assets and ¥7,665 million of liabilities as held for sale in respect of the deal. The transfer completed on July 1, 2026, and Toray expects to recognise a gain on sale of approximately ¥8.0 billion after tax in the interim period. Because core operating income is defined to exclude non-recurring items, a disposal gain of this kind would land in reported profit and in the ¥45.0 billion interim parent-profit target rather than in the ¥87.0 billion core operating income line — a distinction worth holding onto when the half-year numbers arrive. Toray reported no other material subsequent events, and the quarterly consolidated financial statements were not subject to audit or review.

JapanStockPulse provides informational content only and does not constitute investment advice. Figures are taken from the company's published earnings short report and may be subject to subsequent revision.